drugset / Trial / NCT04333134
A Trial of SHR3162 in Healthy Caucasian Volunteers
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety and PK characteristics of a single oral dose of fluzoparib in healthy Caucasian and Chinese subjects
Timeline
- Start
- 2020-04-17
- Primary completion
- 2020-05-15
- Completion
- 2020-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fluzoparib | Small molecule | — | Oral |
Indications
No indication recorded.